Copyright Reports & Markets. All rights reserved.

Global and China Induced Pluripotent Stem Cells Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Induced Pluripotent Stem Cells Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 Hepatocytes
    • 1.2.3 Fibroblasts
    • 1.2.4 Keratinocytes
    • 1.2.5 Amniotic Cells
    • 1.2.6 Others
  • 1.3 Market by Application
    • 1.3.1 Global Induced Pluripotent Stem Cells Market Share by Application: 2020 VS 2026
    • 1.3.2 Academic Research
    • 1.3.3 Drug Development And Discovery
    • 1.3.4 Toxicity Screening
    • 1.3.5 Regenerative Medicine
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Induced Pluripotent Stem Cells Market Perspective (2015-2026)
  • 2.2 Global Induced Pluripotent Stem Cells Growth Trends by Regions
    • 2.2.1 Induced Pluripotent Stem Cells Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Induced Pluripotent Stem Cells Historic Market Share by Regions (2015-2020)
    • 2.2.3 Induced Pluripotent Stem Cells Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Induced Pluripotent Stem Cells Players by Market Size
    • 3.1.1 Global Top Induced Pluripotent Stem Cells Players by Revenue (2015-2020)
    • 3.1.2 Global Induced Pluripotent Stem Cells Revenue Market Share by Players (2015-2020)
  • 3.2 Global Induced Pluripotent Stem Cells Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Induced Pluripotent Stem Cells Revenue
  • 3.4 Global Induced Pluripotent Stem Cells Market Concentration Ratio
    • 3.4.1 Global Induced Pluripotent Stem Cells Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Induced Pluripotent Stem Cells Revenue in 2019
  • 3.5 Key Players Induced Pluripotent Stem Cells Area Served
  • 3.6 Key Players Induced Pluripotent Stem Cells Product Solution and Service
  • 3.7 Date of Enter into Induced Pluripotent Stem Cells Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Induced Pluripotent Stem Cells Breakdown Data by Type (2015-2026)

  • 4.1 Global Induced Pluripotent Stem Cells Historic Market Size by Type (2015-2020)
  • 4.2 Global Induced Pluripotent Stem Cells Forecasted Market Size by Type (2021-2026)

5 Induced Pluripotent Stem Cells Breakdown Data by Application (2015-2026)

  • 5.1 Global Induced Pluripotent Stem Cells Historic Market Size by Application (2015-2020)
  • 5.2 Global Induced Pluripotent Stem Cells Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Induced Pluripotent Stem Cells Market Size (2015-2026)
  • 6.2 North America Induced Pluripotent Stem Cells Market Size by Type (2015-2020)
  • 6.3 North America Induced Pluripotent Stem Cells Market Size by Application (2015-2020)
  • 6.4 North America Induced Pluripotent Stem Cells Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Induced Pluripotent Stem Cells Market Size (2015-2026)
  • 7.2 Europe Induced Pluripotent Stem Cells Market Size by Type (2015-2020)
  • 7.3 Europe Induced Pluripotent Stem Cells Market Size by Application (2015-2020)
  • 7.4 Europe Induced Pluripotent Stem Cells Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Induced Pluripotent Stem Cells Market Size (2015-2026)
  • 8.2 China Induced Pluripotent Stem Cells Market Size by Type (2015-2020)
  • 8.3 China Induced Pluripotent Stem Cells Market Size by Application (2015-2020)
  • 8.4 China Induced Pluripotent Stem Cells Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Induced Pluripotent Stem Cells Market Size (2015-2026)
  • 9.2 Japan Induced Pluripotent Stem Cells Market Size by Type (2015-2020)
  • 9.3 Japan Induced Pluripotent Stem Cells Market Size by Application (2015-2020)
  • 9.4 Japan Induced Pluripotent Stem Cells Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Induced Pluripotent Stem Cells Market Size (2015-2026)
  • 10.2 Southeast Asia Induced Pluripotent Stem Cells Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Induced Pluripotent Stem Cells Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Induced Pluripotent Stem Cells Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

  • 11.1 Fujifilm Holding Corporation
    • 11.1.1 Fujifilm Holding Corporation Company Details
    • 11.1.2 Fujifilm Holding Corporation Business Overview
    • 11.1.3 Fujifilm Holding Corporation Induced Pluripotent Stem Cells Introduction
    • 11.1.4 Fujifilm Holding Corporation Revenue in Induced Pluripotent Stem Cells Business (2015-2020))
    • 11.1.5 Fujifilm Holding Corporation Recent Development
  • 11.2 Astellas Pharma
    • 11.2.1 Astellas Pharma Company Details
    • 11.2.2 Astellas Pharma Business Overview
    • 11.2.3 Astellas Pharma Induced Pluripotent Stem Cells Introduction
    • 11.2.4 Astellas Pharma Revenue in Induced Pluripotent Stem Cells Business (2015-2020)
    • 11.2.5 Astellas Pharma Recent Development
  • 11.3 Fate Therapeutics
    • 11.3.1 Fate Therapeutics Company Details
    • 11.3.2 Fate Therapeutics Business Overview
    • 11.3.3 Fate Therapeutics Induced Pluripotent Stem Cells Introduction
    • 11.3.4 Fate Therapeutics Revenue in Induced Pluripotent Stem Cells Business (2015-2020)
    • 11.3.5 Fate Therapeutics Recent Development
  • 11.4 Bristol-Myers Squibb Company
    • 11.4.1 Bristol-Myers Squibb Company Company Details
    • 11.4.2 Bristol-Myers Squibb Company Business Overview
    • 11.4.3 Bristol-Myers Squibb Company Induced Pluripotent Stem Cells Introduction
    • 11.4.4 Bristol-Myers Squibb Company Revenue in Induced Pluripotent Stem Cells Business (2015-2020)
    • 11.4.5 Bristol-Myers Squibb Company Recent Development
  • 11.5 ViaCyte
    • 11.5.1 ViaCyte Company Details
    • 11.5.2 ViaCyte Business Overview
    • 11.5.3 ViaCyte Induced Pluripotent Stem Cells Introduction
    • 11.5.4 ViaCyte Revenue in Induced Pluripotent Stem Cells Business (2015-2020)
    • 11.5.5 ViaCyte Recent Development
  • 11.6 Celgene Corporation
    • 11.6.1 Celgene Corporation Company Details
    • 11.6.2 Celgene Corporation Business Overview
    • 11.6.3 Celgene Corporation Induced Pluripotent Stem Cells Introduction
    • 11.6.4 Celgene Corporation Revenue in Induced Pluripotent Stem Cells Business (2015-2020)
    • 11.6.5 Celgene Corporation Recent Development
  • 11.7 Aastrom Biosciences
    • 11.7.1 Aastrom Biosciences Company Details
    • 11.7.2 Aastrom Biosciences Business Overview
    • 11.7.3 Aastrom Biosciences Induced Pluripotent Stem Cells Introduction
    • 11.7.4 Aastrom Biosciences Revenue in Induced Pluripotent Stem Cells Business (2015-2020)
    • 11.7.5 Aastrom Biosciences Recent Development
  • 11.8 Acelity Holdings
    • 11.8.1 Acelity Holdings Company Details
    • 11.8.2 Acelity Holdings Business Overview
    • 11.8.3 Acelity Holdings Induced Pluripotent Stem Cells Introduction
    • 11.8.4 Acelity Holdings Revenue in Induced Pluripotent Stem Cells Business (2015-2020)
    • 11.8.5 Acelity Holdings Recent Development
  • 11.9 StemCells
    • 11.9.1 StemCells Company Details
    • 11.9.2 StemCells Business Overview
    • 11.9.3 StemCells Induced Pluripotent Stem Cells Introduction
    • 11.9.4 StemCells Revenue in Induced Pluripotent Stem Cells Business (2015-2020)
    • 11.9.5 StemCells Recent Development
  • 11.10 Japan Tissue Engineering
    • 11.10.1 Japan Tissue Engineering Company Details
    • 11.10.2 Japan Tissue Engineering Business Overview
    • 11.10.3 Japan Tissue Engineering Induced Pluripotent Stem Cells Introduction
    • 11.10.4 Japan Tissue Engineering Revenue in Induced Pluripotent Stem Cells Business (2015-2020)
    • 11.10.5 Japan Tissue Engineering Recent Development
  • 11.11 Organogenesis
    • 10.11.1 Organogenesis Company Details
    • 10.11.2 Organogenesis Business Overview
    • 10.11.3 Organogenesis Induced Pluripotent Stem Cells Introduction
    • 10.11.4 Organogenesis Revenue in Induced Pluripotent Stem Cells Business (2015-2020)
    • 10.11.5 Organogenesis Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Induced Pluripotent Stem Cells Scope and Market Size
    Induced Pluripotent Stem Cells market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Induced Pluripotent Stem Cells market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Hepatocytes
    Fibroblasts
    Keratinocytes
    Amniotic Cells
    Others

    Market segment by Application, split into
    Academic Research
    Drug Development And Discovery
    Toxicity Screening
    Regenerative Medicine

    Based on regional and country-level analysis, the Induced Pluripotent Stem Cells market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global Induced Pluripotent Stem Cells market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Fujifilm Holding Corporation
    Astellas Pharma
    Fate Therapeutics
    Bristol-Myers Squibb Company
    ViaCyte
    Celgene Corporation
    Aastrom Biosciences
    Acelity Holdings
    StemCells
    Japan Tissue Engineering
    Organogenesis

    Buy now